Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial.
Br J Dermatol
; 167(5): 1138-44, 2012 Nov.
Article
in En
| MEDLINE
| ID: mdl-23039171
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Pyrimidines
/
Skin
/
Scleroderma, Diffuse
/
Protein Kinase Inhibitors
Type of study:
Clinical_trials
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Dermatol
Year:
2012
Document type:
Article